Chemistry Ventures is raising $500 million for its second fund, aiming to back early-stage startups in sectors such as AI, fintech, and healthcare. The announcement came this week as the firm seeks to build on the momentum from its debut fund, which focused on technology-driven companies. The new fund will enable Chemistry Ventures to expand its portfolio and support more founders in emerging tech markets, according to techcrunch.com.
The fundraising process for the second fund began earlier this year, with Chemistry Ventures engaging institutional investors and limited partners to secure commitments. The firm’s leadership highlighted the strong performance of their initial investments as a key factor in attracting capital. Chemistry Ventures plans to deploy the $500 million across multiple rounds, focusing on startups that demonstrate scalable business models and innovative technology applications, techcrunch.com reported.
This $500 million fundraise positions Chemistry Ventures among the larger early-stage venture capital firms targeting technology startups. The fund size reflects growing investor interest in sectors like AI and fintech, which have seen increased deal activity and valuations recently. Comparable funds in the space have raised similar amounts, underscoring the competitive landscape for promising startups. Chemistry Ventures’ focus on these sectors aligns with broader market trends where technology innovation continues to drive investment flows, according to techcrunch.com.
Chemistry Ventures’ second fundraise will allow the firm to increase its investments and support startups through critical growth phases. The firm has scheduled a series of investor meetings over the next quarter to finalize commitments. The $500 million target represents a significant step up from their first fund, which closed at a smaller amount, marking a milestone in the firm’s growth trajectory, as detailed by techcrunch.com.